Anavex Life Sciences (AVXL) News Today $11.30 +2.67 (+30.94%) (As of 03:04 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Anavex Life Sciences Corp.: Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer's DiseaseDecember 23 at 1:19 PM | finanznachrichten.deBlarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s DiseaseDecember 23 at 1:19 PM | finance.yahoo.comAnavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business UpdateDecember 23 at 1:19 PM | markets.businessinsider.comAnavex Life Sciences (NASDAQ:AVXL) Sets New 12-Month High After Earnings BeatAnavex Life Sciences (NASDAQ:AVXL) Sets New 1-Year High After Strong EarningsDecember 23 at 10:29 AM | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Receives "Buy" Rating from D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and issued a $46.00 price objective on shares of Anavex Life Sciences in a research note on Monday.December 23 at 9:09 AM | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Releases Earnings Results, Beats Expectations By $0.03 EPSAnavex Life Sciences (NASDAQ:AVXL - Get Free Report) announced its quarterly earnings data on Monday. The biotechnology company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.03.December 23 at 8:30 AM | marketbeat.comAnavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business UpdateDecember 23 at 7:30 AM | globenewswire.comBlarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer's DiseaseDecember 23 at 7:00 AM | globenewswire.comWhat To Expect in the Markets This WeekDecember 22 at 5:25 AM | investopedia.comAnavex Life Sciences (NASDAQ:AVXL) Trading 8.5% Higher - Time to Buy?Anavex Life Sciences (NASDAQ:AVXL) Trading Up 8.5% - Still a Buy?December 16, 2024 | marketbeat.comAnavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024December 16, 2024 | globenewswire.comAnavex Life Sciences (NASDAQ:AVXL) Shares Gap Up - Here's What HappenedDecember 15, 2024 | americanbankingnews.comAnavex Life Sciences (NASDAQ:AVXL) Shares Gap Up - Here's WhyAnavex Life Sciences (NASDAQ:AVXL) Shares Gap Up - Time to Buy?December 13, 2024 | marketbeat.comAnavex announces upcoming presentation of data from ATTENTION-AD studyDecember 9, 2024 | markets.businessinsider.comAnavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare ConferenceDecember 9, 2024 | markets.businessinsider.comAnavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer's Disease Data at J.P. Morgan 2025 Healthcare ConferenceDecember 9, 2024 | globenewswire.comAnavex: EU Approval Application Is A Precipitous MomentDecember 8, 2024 | seekingalpha.comAnavex Life Sciences (NASDAQ:AVXL) Trading Up 7.8% - Should You Buy?Anavex Life Sciences (NASDAQ:AVXL) Trading Up 7.8% - What's Next?December 6, 2024 | marketbeat.comAnavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024December 2, 2024 | globenewswire.comAnavex Life Sciences (NASDAQ:AVXL) Stock Price Up 8.1% - Still a Buy?Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 8.1% - Time to Buy?November 29, 2024 | marketbeat.comBuy Recommendation for Anavex Life Sciences: Promising Alzheimer’s Treatment and Expanding Clinical PipelineNovember 28, 2024 | markets.businessinsider.comAnavex Life Sciences (NASDAQ:AVXL) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $40.00 price objective on shares of Anavex Life Sciences in a research note on Wednesday.November 27, 2024 | marketbeat.comAnavex Life Sciences Corp.: Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer's Disease to EMANovember 26, 2024 | finanznachrichten.deAnavex gains after seeking EU marketing nod for Alzheimer’s drugNovember 26, 2024 | msn.comAnavex Stock Jumps Pre-Market After Submitting Oral Alzheimer's Drug To European Regulators For Approval: Retail Over The MoonNovember 26, 2024 | msn.comAnavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMANovember 26, 2024 | markets.businessinsider.comAnavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer's Disease to EMANovember 26, 2024 | globenewswire.comAnavex announces acceptance of manuscript on blarcamesine Phase IIb/III dataNovember 25, 2024 | markets.businessinsider.comD. Boral says Anavex Alzheimer’s approach superior to CassavaNovember 25, 2024 | markets.businessinsider.comAnavex Life Sciences' (AVXL) "Buy" Rating Reaffirmed at D. Boral CapitalD. Boral Capital reiterated a "buy" rating and issued a $46.00 price target on shares of Anavex Life Sciences in a research note on Monday.November 25, 2024 | marketbeat.comAnavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer's Disease JournalNovember 25, 2024 | globenewswire.comAnavex Life Sciences (NASDAQ:AVXL) Trading Down 4.1% - Here's WhyAnavex Life Sciences (NASDAQ:AVXL) Shares Down 4.1% - Should You Sell?November 22, 2024 | marketbeat.comNwam LLC Buys Shares of 910,476 Anavex Life Sciences Corp. (NASDAQ:AVXL)Nwam LLC purchased a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 910,476 shares of the biotechnology company's stock, valued atNovember 22, 2024 | marketbeat.comGSA Capital Partners LLP Has $507,000 Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL)GSA Capital Partners LLP trimmed its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 59.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 89,299 shares of the biotechnology company's sNovember 20, 2024 | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Hits New 52-Week High - Still a Buy?Anavex Life Sciences (NASDAQ:AVXL) Hits New 1-Year High - What's Next?November 11, 2024 | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Stock, Insider Trading ActivityNovember 9, 2024 | benzinga.comAnavex Life Sciences (NASDAQ:AVXL) Shares Up 8.1% - Here's WhyAnavex Life Sciences (NASDAQ:AVXL) Trading Up 8.1% - Time to Buy?November 8, 2024 | marketbeat.comAnavex Life Sciences: Weighing The Pros And Cons Of A Possible EU Approval ScenarioNovember 6, 2024 | seekingalpha.comAnavex: Understanding Their Latest Alzheimer's Data News With CautionNovember 5, 2024 | seekingalpha.comAnavex Life Sciences: Buy Rating Driven by Promising Blarcamesine Developments and Market ExpansionNovember 4, 2024 | markets.businessinsider.comAnavex Life Sciences' (AVXL) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $40.00 target price on shares of Anavex Life Sciences in a research report on Monday.November 4, 2024 | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Stock, Option ChainNovember 1, 2024 | benzinga.comAnavex Life Sciences (NASDAQ:AVXL) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comAnavex Life Sciences’ Promising Alzheimer’s Drug: Buy Rating Justified by Positive Clinical Outcomes and Strategic AdvantagesOctober 31, 2024 | markets.businessinsider.comAnavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024October 31, 2024 | markets.businessinsider.comAnavex's Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer's Trial: Data Presented at CTAD Conference 2024October 31, 2024 | globenewswire.comBuy Rating Affirmed for Anavex Life Sciences Amid Promising Clinical Developments and Market ProspectsOctober 19, 2024 | markets.businessinsider.comAnavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $40.00 price objective on shares of Anavex Life Sciences in a research note on Friday.October 18, 2024 | marketbeat.comAnavex Reports Promising EEG Biomarker Results From Phase 2 Study Of ANAVEX 3-71 For SchizophreniaOctober 17, 2024 | markets.businessinsider.comAnavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of SchizophreniaOctober 17, 2024 | globenewswire.com Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… AVXL Media Mentions By Week AVXL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVXL News Sentiment▼0.630.60▲Average Medical News Sentiment AVXL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVXL Articles This Week▼94▲AVXL Articles Average Week Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RNA News BHVN News VRNA News PTCT News RYTM News MLTX News JANX News MRUS News XENE News ZLAB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVXL) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVXL Stock Alerts